Antipodean Pharmaceuticals, Inc. Announces FDA Acceptance of IND for MitoQ(R)
6/3/2008 9:32:45 AM
More...
|
Antipodean Pharmaceuticals, Inc. Announces Results of Phase 2 Study of Lead Compound MitoQ(R)
4/24/2008 8:27:06 AM
More...
|
Antipodean Pharmaceuticals, Inc. Announces Completion of Phase 2 Study of Lead Compound MitoQ(R)
4/10/2008 11:09:28 AM
More...
|
Antipodean Pharmaceuticals, Inc. Initiates Phase 2 Trial In Hepatitis C
2/5/2007 12:50:52 PM
More...
|
Antipodean Pharmaceuticals, Inc. Completes Phase 2 Trial Enrollment For MitoQ In Parkinson's Disease
11/27/2006 11:11:12 AM
More...
|
Antipodean Pharmaceuticals Inc. Initiates Phase 2 Trial In Parkinson's Disease
5/25/2006 10:22:26 AM
More...
|
Antipodean Pharmaceuticals Inc. Establishes San Francisco Headquarters
4/11/2006 10:29:02 AM
More...
|